BACE1 (β-secretase) knockout mice do not acquire compensatory gene expression changes or develop neural lesions over time
The formation of Alzheimer's Aβ peptide is initiated when the amyloid precursor protein (APP) is cleaved by the enzyme β-secretase (BACE1); inhibition of this cleavage has been proposed as a means of treating Alzheimer's disease. (AD) We have previously shown that young BACE1 knockout mice...
Main Authors: | Yi Luo, Brad Bolon, Michael A Damore, Dan Fitzpatrick, Hantao Liu, Jianhua Zhang, Qiao Yan, Robert Vassar, Martin Citron |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2003-10-01
|
Series: | Neurobiology of Disease |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0969996103001049 |
Similar Items
-
BACE1 gene deletion prevents neuron loss and memory deficits in 5XFAD APP/PS1 transgenic mice
by: Masuo Ohno, et al.
Published: (2007-04-01) -
Glycosaminoglycans from <i>Litopenaeus vannamei</i> Inhibit the Alzheimer’s Disease β Secretase, BACE1
by: Courtney J. Mycroft-West, et al.
Published: (2021-04-01) -
Discovery of polymethoxyflavones from black ginger (Kaempferia parviflora) as potential β-secretase (BACE1) inhibitors
by: Kumju Youn, et al.
Published: (2016-01-01) -
Role of BACE1 in Alzheimer’s synaptic function
by: Brati Das, et al.
Published: (2017-08-01) -
BACE-1 and γ-Secretase as Therapeutic Targets for Alzheimer’s Disease
by: Miguel A. Maia, et al.
Published: (2019-03-01)